LU77353A1 - - Google Patents

Info

Publication number
LU77353A1
LU77353A1 LU77353A LU77353A LU77353A1 LU 77353 A1 LU77353 A1 LU 77353A1 LU 77353 A LU77353 A LU 77353A LU 77353 A LU77353 A LU 77353A LU 77353 A1 LU77353 A1 LU 77353A1
Authority
LU
Luxembourg
Application number
LU77353A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to LU77353A priority Critical patent/LU77353A1/xx
Priority to FR7814338A priority patent/FR2390959A1/fr
Publication of LU77353A1 publication Critical patent/LU77353A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU77353A 1977-05-16 1977-05-16 LU77353A1 (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (da) 1977-05-16 1977-05-16
FR7814338A FR2390959A1 (fr) 1977-05-16 1978-05-12 Association therapeutique a visee anti-agregante et regularisatrice de la duree de vie plaquettaire a base de pyrimido-pyrimidine et d'acide acetyl salycilique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77353A LU77353A1 (da) 1977-05-16 1977-05-16

Publications (1)

Publication Number Publication Date
LU77353A1 true LU77353A1 (da) 1979-01-19

Family

ID=19728580

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77353A LU77353A1 (da) 1977-05-16 1977-05-16

Country Status (2)

Country Link
FR (1) FR2390959A1 (da)
LU (1) LU77353A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470600A2 (fr) * 1979-12-07 1981-06-12 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
FR2452922A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2452923A2 (fr) * 1979-04-02 1980-10-31 Panoz Donald Nouvelle forme galenique d'administration de medicaments par voie orale, a liberation programmee
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
FR2494112B1 (da) * 1980-11-19 1986-01-10 Laruelle Claude
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
FR2513118A1 (fr) * 1981-09-18 1983-03-25 Rocador Sa Composition pharmaceutique a base de dipyridamol et de sel d'aluminium de l'acide acetylsalicylique pour combattre l'agregation plaquettaire
FR2539995B1 (fr) * 1983-01-28 1985-08-16 Sanofi Sa Medicament a liberation programmee a base d'acide acetylsalicylique
ATE50497T1 (de) * 1984-07-21 1990-03-15 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
AT393962B (de) * 1987-10-22 1992-01-10 Thomae Gmbh Dr K Synergistische arzneimittelkombination mit einem gehalt an einem phosphodiesterase-hemmer und derenverwendung
US5041430A (en) * 1989-09-18 1991-08-20 Du Pont Mereck Pharmaceutical Company Oral anticoagulant/platelet inhibitor low dose formulation
FR2681596B1 (fr) * 1991-09-23 1993-11-26 Thomas Andre Procede de preparation d'acetylsalicylates des bases puriques et pyrimidiques et de leurs nucleosides.
WO2010036975A2 (en) * 2008-09-25 2010-04-01 Teva Pharmaceutical Industries Ltd. Dipyridamole and acetylsalicylic acid formulations and process for preparing same

Also Published As

Publication number Publication date
FR2390959A1 (fr) 1978-12-15
FR2390959B1 (da) 1983-03-25

Similar Documents

Publication Publication Date Title
AU3353778A (da)
AU495917B2 (da)
AR210643A1 (da)
AU71461S (da)
BG25847A1 (da)
BG25825A1 (da)
BE851449A (da)
BE865722A (da)
BE866391A (da)
BE868323A (da)
BE870787A (da)
BE871419A (da)
BE871991A (da)
BE872973A (da)
BE873002A (da)
BG23438A1 (da)
BG23462A1 (da)
BG24331A1 (da)
BG24713A1 (da)
BG25808A1 (da)
BG25809A1 (da)
BG25810A1 (da)
BG25811A1 (da)
BG25812A1 (da)
BG25813A1 (da)